Relationship between S100A11 expression and clinicopathologic characteristics of stage I lung adenocarcinomas.

No., number of cases; WEL, well differentiated; MOD, moderately differentiated; POR, poorly differentiated carcinomas; AIS, adenocarcinoma in situ; MIA, minimally invasive adenocarcinoma; LEP, lepidic predominant; ACN, acinar predominant; PAP, papillary predominant, SOL, solid predominant; MUC, invasive mucinous adenocarcinoma.Histologic subtypes were classified according to the 2011 IASLC/ ATS/ETS classification of lung adenocarcinoma.P, significant level for Mann-Whitney or Kruskal-Wallis test.Relationship between S100A11 expression and clinicopathologic characteristics of stage I lung adenocarcinomas.序号（No.）、病例数；WEL（高分化，well differentiated）、MOD（中分化，moderately differentiated）、POR（低分化癌，poorly differentiated carcinomas）；AIS（原位腺癌，adenocarcinoma in situ）、MIA（微浸润性腺癌，minimally invasive adenocarcinoma）；LEP（贴壁生长为主型，lepidic predominant）、ACN（腺泡为主型，acinar predominant）、PAP（乳头状为主型，papillary predominant）、SOL（实性为主型，solid predominant）、MUC（浸润性黏液性腺癌，invasive mucinous adenocarcinoma）。组织学亚型参照2011年国际肺癌研究协会（IASLC）、美国胸科学会（ATS）与欧洲呼吸学会（ETS）联合发布的肺腺癌分类标准进行分型。P值为Mann-Whitney检验或Kruskal-Wallis检验的显著性水平。本研究探讨Ⅰ期肺腺癌患者S100A11表达与临床病理特征的相关性。